TMCnet News
Rush-Copley Medical Center Successfully Activates Eclipsys' Sunrise Clinical Manager 3.5 XA; Clinicians Report Excellent Response Times and Robust Functionality AURORA, Ill. & BOCA RATON, Fla. --(Business Wire)-- Oct. 4, 2004 -- Eclipsys Corporation(R), The Outcomes Company(R), (Nasdaq:ECLP), today announced that Rush-Copley Medical Center has successfully activated Eclipsys' Sunrise(TM) Clinical Manager 3.5 XA(TM) advanced clinical software solution. Rush-Copley officials, physicians and staff report excellent response times using Sunrise Clinical Manager 3.5 XA. The activation occurred less than three months after the general availability of the advanced software solution."The smooth implementation of Sunrise Clinical Manager 3.5 XA is an important milestone," said Beckie Coovert, director of information services at Rush-Copley. "Our physicians and clinicians are reporting excellent response times and are excited about the robust functionality provided in Sunrise Clinical Manager 3.5 XA." Rush-Copley clinicians are utilizing Sunrise Clinical Manager 3.5 XA throughout the enterprise for order entry and results viewing. The advanced clinical solution provides Rush-Copley's clinicians with immediate access to patient medical records, lab results and integrated clinical content at the point of care. Later this year, Rush-Copley will implement the solution's Knowledge-Based Charting capabilities. Knowledge-Based Charting is a comprehensive interdisciplinary documentation solution for nurses and clinicians. In early 2005, the medical center will implement Eclipsys' Sunrise Medication Management software, a closed-loop solution using bar code technology that will provide clinical decision support at the point of care. The medication management solution will link physicians as they place orders, pharmacists as they verify and dispense orders, and nurses as they administer medications. Sunrise Medication Management eliminates the error-prone process of manually transcribing physician orders into a pharmacy system. The result is improved workflow and increased patient safety. Release 3.5 represents next phase in evolution Sunrise Clinical Manager release 3.5 XA represents the next phase in the evolution of Eclipsys' advanced clinical solutions. Release 3.5 has significantly more functionality than previous releases of Eclipsys' award-winning Sunrise Clinical Manager. Release 3.5 includes significant additional functionality for core clinical, ambulatory and emergency department solutions as well as enhancements to its patient management functions. Release 3.5 also extends support for physicians through the inclusion of advanced functionality for clinical decision support, structured notes, medical necessity checking, prescription writing and medication management configuration. Release 3.5 XA includes significant enhancements in remote access services, furthering Eclipsys' vision of "anytime and anywhere" accessibility by physicians. With this capability, physicians can review patient results, view documents, access secure health messaging and obtain clinical patient summaries securely from home, the office, the airport or elsewhere, thereby increasing the speed, continuity and efficiency of care delivery. Sunrise Clinical Manager 3.5 XA also extends support for nurses and clinicians by including significant additional clinical documentation and Knowledge-Based Charting capabilities. Release 3.5 is preconfigured for use with evidence-based medical content to support best-practice treatment plans. The incorporation of clinical practice guidelines within release 3.5 XA helps healthcare organizations meet the professional standards of the Joint Commission on Accreditation of Healthcare Organizations (JCAHO) and the Magnet Recognition Program for nurses. Independent third-party testing Sunrise Clinical Manager 3.5 XA was subjected to extensive internal testing before its general availability on June 30, 2004. "Release 3.5 reflects Eclipsys' attention to the high quality and robust performance that our customers expect and require," said John Gomez, Eclipsys' chief technology and strategy officer. Gomez noted that Sunrise Clinical Manager 3.5 XA has been analyzed by Aberdeen Group, an independent research firm. Results of that analysis are expected to be released in the coming weeks. "As one of our premier customers, Rush-Copley is consistently implementing our latest solutions as part of a shared vision for enhancing quality of care," said Paul L. Ruflin, Eclipsys president and CEO. "As we usher in the 'Decade of Health Information Technology,' Rush-Copley Medical Center is playing a leading role in fulfilling the government's goal of paperless hospitals." About Rush-Copley Medical Center Located near Chicago, Rush-Copley Medical Center is a 150-bed hospital offering a full spectrum of healthcare services. Rush-Copley is a member of the Rush-System for Health. About Eclipsys Eclipsys is a leading provider of advanced clinical, financial and management information software and service solutions to more than 1,500 healthcare facilities. Eclipsys empowers healthcare organizations to improve patient safety, revenue cycle management and operational efficiency through innovative information solutions. For more information, see http://www.eclipsys.com or e-mail [email protected]. Statements in this news release concerning future results, performance or expectations are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. All forward-looking statements included in this document are based upon information available to Eclipsys as of the date hereof and Eclipsys assumes no obligation to update any such forward-looking statements. Because such statements involve risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. These risks include several risks in connection with our SunriseXA strategy, including the uncertainty of the time and costs required to implement the strategy, the potential that our strategy could change, the potential that we may encounter technical difficulties in implementing our strategy, and the potential that the changes to our products may affect customer demand. Other risks include potential financial constraints and other factors faced by the healthcare industry, changing customer requirements and other risks described in the filings of Eclipsys with the Securities and Exchange Commission, including its annual report on Form 10-Q for the quarter ended June 30, 2004. Eclipsys, Eclipsys Corporation and The Outcomes Company are registered trademarks of Eclipsys Corporation. Sunrise and XA are trademarks of Eclipsys Technologies Corporation. Other product and company names in this news release are trademarks or registered trademarks of their respective companies. |

